Beckman Coulter Life Sciences announced a strategic integration with Automata that embeds Beckman liquid‑handling and analysis instruments into Automata’s LINQ automation ecosystem. Danaher Ventures joined Automata’s Series C and will take a board seat, supporting joint development and commercial scale‑up. The collaboration aims to enable AI‑ready, modular lab workcells with unified orchestration, improving workflow reliability, data integrity, and autonomous operation for high‑throughput R&D. Beckman framed the deal as enabling ‘agentic AI’ in wet labs to accelerate discovery and reproducibility. Automata separately closed a $45 million Series C round that includes strategic investment from Danaher. The funding will scale deployments and advance closed‑loop experimentation software, signaling growing investor appetite for end‑to‑end lab automation platforms that pair hardware with AI orchestration.